XML 42 R30.htm IDEA: XBRL DOCUMENT v3.21.1
Stock Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Stock Based Compensation [Abstract]  
Weighted-Average Assumptions for Stock Options

The weighted average assumptions that the Company used in the Black-Scholes pricing model to determine the fair value of the stock options granted to employees, non-employees and directors were as follows:

 
Three Months Ended March 31,
 
 
 
2021
   
2020
 
 
     
Risk-free interest rate
   
0.62
%
   
1.48
%
Expected term (in years)
   
5.87
     
5.87
 
Expected volatility
   
69.41
%
   
77.75
%
Expected dividend yield
   
0.00
%
   
0.00
%
Exercise price
 
$
36.99
   
$
22.47
 
Fair value of common stock
 
$
36.99
   
$
22.47
 
Stock Option Activity

The following table summarizes stock option activity for the three months ended March 31, 2021 under the Second Amended and Restated 2014 Stock Option and Incentive Plan:

 
 
Number of
Shares
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Contractual
Term (Years)
   
Aggregate
Intrinsic
Value
 
 
                       
Outstanding as of December 31, 2020
   
11,050,931
   
$
9.10
     
6.55
   
$
504,079
 
Granted
   
916,575
     
60.95
     
10.64
         
Exercised
   
(991,432
)
   
8.31
             
51,892
 
Cancelled
   
(83,244
)
   
31.82
                 
Outstanding as of March 31, 2021
   
10,892,830
   
$
13.42
     
6.57
   
$
349,406
 
 
                               
Options vested and exercisable as of March 31, 2021
   
7,856,137
   
$
5.70
     
5.55
   
$
300,452
 
Options unvested as of March 31, 2021
   
3,036,693
   
$
33.17
     
9.20
         
Stock-Based Compensation Expense by Award Type

Stock-based compensation expense recognized by award type was as follows:

 
Three Months Ended March 31,
 
 
 
2021
   
2020
 
 
     
Stock options
 
$
7,826
   
$
3,961
 
Restricted stock units
   
74
     
-
 
Total share based compensation expense
 
$
7,900
   
$
3,961
 
Stock-Based Compensation Expense

Stock-based compensation expense by classification included within the consolidated statements of operations and comprehensive loss was as follows:

 
Three Months Ended March 31,
 
 
 
2021
   
2020
 
 
     
Research and development
 
$
2,916
   
$
1,735
 
General and administrative
   
4,984
     
2,226
 
Total share based compensation expense
 
$
7,900
   
$
3,961
 
RSU Activity

The following table summarizes our RSU activity for the three months ended March 31, 2021:

 
Number of
Shares
   
Weighted
Average
Grant Date
Fair Value
 
             
Unvested as of December 31, 2020
   
20,000
   
$
25.06
 
Granted
   
3,500
     
62.32
 
Vested
   
-
     
-
 
Forfeited
   
-
     
-
 
Unvested as of March 31, 2021
   
23,500
     
30.61